Pharmacology, Toxicology and Pharmaceutical Science
Very Late Activation Antigen 5
100%
Integrin
100%
Nervous System Inflammation
100%
Blood-Brain Barrier
88%
Multiple Sclerosis
66%
Experimental Autoimmune Encephalomyelitis
55%
Demyelination
22%
Knockout Mouse
22%
Tight Junction Protein
22%
Claudin 5
11%
Experimental Stroke
11%
Intercellular Adhesion Molecule 1
11%
Cell Surface Receptor
11%
Wild Type Mouse
11%
Transgenic Mouse
11%
Infarction
11%
Vascular Remodeling
11%
Inflammatory Disease
11%
Vascular Cell Adhesion Molecule 1
11%
Demyelinating Disease
11%
Brain Ischemia
11%
Fibronectin
11%
Receptor
11%
Hypoxia
11%
Scleroprotein
11%
Cell Adhesion Proteins
11%
Diseases
11%
Immunology and Microbiology
Very Late Activation Antigen 5
100%
Integrin
100%
Blood Brain Barrier
88%
Multiple Sclerosis
66%
Experimental Autoimmune Encephalomyelitis
55%
Leukocyte
33%
Tight Junction
22%
Knockout Mouse
22%
Clinically Isolated Syndrome
11%
Claudin
11%
Central Nervous System
11%
Inflammatory Disorder
11%
Angiogenesis
11%
Intercellular Adhesion Molecule 1
11%
Axon
11%
Cell Surface
11%
Gene Deletion
11%
Matrix Protein
11%
Extracellular Matrix
11%
Wild Type Mouse
11%
Transgenic Mouse
11%
Parenchyma
11%
VCAM-1
11%
Fibronectin
11%
Cell Adhesion Proteins
11%
Neuroscience
Integrin
100%
Very Late Activation Antigen 5
100%
Blood Brain Barrier
88%
Multiple Sclerosis
66%
Experimental Autoimmune Encephalomyelitis
55%
Leukocyte
33%
Tight Junction Protein
22%
Central Nervous System
11%
Claudin 5
11%
Fibronectin
11%
Gene Deletion
11%
VCAM-1
11%
Extracellular Matrix Proteins
11%
Intercellular Adhesion Molecule 1
11%
Brain Ischemia
11%
Cell Surface Receptor
11%
Parenchyma
11%
Angiogenesis
11%
Demyelinating Disease
11%
Cerebrovascular Accident
11%
Receptor
11%
Cell Adhesion Proteins
11%
Axon
11%